Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


3 BMC Cancer
1 Cancer
1 Curr Treat Options Oncol
1 Eur J Cancer
10 Eur J Surg Oncol
7 Gastroenterology
2 Int J Cancer
1 Int J Colorectal Dis
2 Oncol Rep
4 PLoS One

    BMC Cancer

  1. BRONZWAER MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, et al
    Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
    BMC Cancer. 2018;18:465.
    >> Share

  2. ARROSPIDE A, Idigoras I, Mar J, de Koning H, et al
    Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
    BMC Cancer. 2018;18:464.
    >> Share

  3. MUNKER S, Gerken M, Fest P, Ott C, et al
    Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
    BMC Cancer. 2018;18:455.
    >> Share


  4. KARUTURI MS, Holmes HM, Lei X, Johnson M, et al
    Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Cancer. 2018 Apr 24. doi: 10.1002/cncr.31403.
    >> Share

    Curr Treat Options Oncol

  5. LAM M, Loree JM, Pereira AAL, Chun YS, et al
    Correction to: Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer.
    Curr Treat Options Oncol. 2018;19:25.
    >> Share

    Eur J Cancer

  6. MARGALIT O, Mamtani R, Yang YX, Reiss KA, et al
    A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
    Eur J Cancer. 2018;96:105-110.
    >> Share

    Eur J Surg Oncol

  7. HUISKENS J, Olthof PB, van der Stok EP, Bais T, et al
    Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
    Eur J Surg Oncol. 2018;44:108-114.
    >> Share

  8. JONES HJS, Cunningham C, Nicholson GA, Hompes R, et al
    Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
    Eur J Surg Oncol. 2018;44:15-23.
    >> Share

  9. SUTTON PA, Jithesh PV, Jones RP, Evans JP, et al
    Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
    Eur J Surg Oncol. 2018;44:115-121.
    >> Share

  10. DUPRE A, Malik HZ, Jones RP, Diaz-Nieto R, et al
    Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:80-86.
    >> Share

  11. LINTER KAPISINSKA M, Hovorkova E, Zavalova V, Subrt Z, et al
    Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers.
    Eur J Surg Oncol. 2018;44:87-92.
    >> Share

  12. STIFT J, Graf A, Schwarz C, Tamandl D, et al
    Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:139-147.
    >> Share

  13. OMICHI K, Shindoh J, Cloyd JM, Mizuno T, et al
    Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Eur J Surg Oncol. 2018;44:122-129.
    >> Share

  14. SAO JULIAO GP, Habr-Gama A, Vailati BB, Aguilar PB, et al
    Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    Eur J Surg Oncol. 2018;44:93-99.
    >> Share

  15. WESTBERG K, Palmer G, Hjern F, Johansson H, et al
    Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Eur J Surg Oncol. 2018;44:100-107.
    >> Share

  16. FALCAO D, Alexandrino H, Caetano Oliveira R, Martins J, et al
    Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Eur J Surg Oncol. 2018 Apr 11. pii: S0748-7983(18)30992.
    >> Share


  17. LI T, Hao CY, Zhang ZL
    Hematochezia Caused by a Colon Disease With Unusual Presentation.
    Gastroenterology. 2018;154:e1-e3.
    >> Share

  18. HSU MH, Chen YJ, Wang WL
    An Unusual Colon Cystic Tumor.
    Gastroenterology. 2018;154:1244-1245.
    >> Share

  19. OZAWA T, Kandimalla R, Gao F, Nozawa H, et al
    A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
    Gastroenterology. 2018;154:844-848.
    >> Share

  20. HE X, Wu K, Ogino S, Giovannucci EL, et al
    Association between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30480.
    >> Share

  21. NAKATSU G, Zhou H, Wu WKK, Wong SH, et al
    Alterations in Enteric Virome Associate With Colorectal Cancer and Survival Outcomes.
    Gastroenterology. 2018 Apr 21. pii: S0016-5085(18)30479.
    >> Share

  22. KNIELING F, Gonzales Menezes J, Claussen J, Schwarz M, et al
    Raster-Scanning Optoacoustic Mesoscopy for Gastrointestinal Imaging at High Resolution.
    Gastroenterology. 2018;154:807-809.
    >> Share

  23. SHARMA D, Malik A, Guy CS, Karki R, et al
    Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.
    Gastroenterology. 2018;154:948-964.
    >> Share

    Int J Cancer

  24. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
    A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
    >> Share

  25. CHEN L, Pan X, Hu X, Zhang YH, et al
    Gene expression differences among different MSI statuses in colorectal cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
    >> Share

    Int J Colorectal Dis

  26. LANDRE T, Maillard E, Taleb C, Ghebriou D, et al
    Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.
    Int J Colorectal Dis. 2018 Apr 21. pii: 10.1007/s00384-018-3053.
    >> Share

    Oncol Rep

  27. ALOWAIDI F, Hashimi SM, Alqurashi N, Alhulais R, et al
    Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6392.
    >> Share

  28. TERASAKI M, Mima M, Kudoh S, Endo T, et al
    Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
    Oncol Rep. 2018 Apr 24. doi: 10.3892/or.2018.6398.
    >> Share

    PLoS One

  29. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    >> Share

  30. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    >> Share

  31. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    >> Share

  32. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016